Pavillon International

Extended care program: patients may individualize their length of stay after primary treatment, and continue in our extended care program if and as needed. Indicators for adding the extended care phase of treatment include matters of clinical complexity such as psychiatric conditions, previous treatment episodes for substance use disorders, previous time in recovery from substance use disorders, adverse factors during their upbringing in their family of origin, current family system dynamics, and personality factors that might serve as barriers to personal recovery. That program specializes in relapse prevention therapy with a focus on navigating underlying core issues in the context of their current life experience that can contribute to the relapse process. During fiscal year ending in 2025, our extended care program treated 107 patients resulting in 2,317 patient days and an average length of stay of 22 days.

Intensive outpatient program (iop): our organization provides a virtual intensive outpatient program (iop) for substance use disorders and this can include people with a co-occurring psychiatric conditions. The iop can serve as the primary treatment for those needing to begin care or as a step-down next level of care from a residential program including programs other than provided by pavillon. The iop is offered in 3 groups per week in a daytime track or an evening track. Following iop we offer a step-down level of care twice per week in the same tracks. We also offer a once-per-week step down level of care following the twice-per-week level. Pavillon provides a 12 month long weekly group therapy on an outpatient basis that specifically focuses on those people with chronic relapse histories and needing to address the underlying dynamics leading to return to use. Individual sessions and psychiatric medication management can be provided for people receiving our outpatient care, if and as needed. Further, we provide an outpatient one day assessment determining the presence or absence of a substance use disorder, if such an extended evaluation method is needed. For fiscal year ending in 2025, we completed a total of 1,659 iop sessions, 323 group therapy sessions, 832 relapse prevention sessions, 864 individual and medication management office visits.